Dr. Jennifer Havens is a naturopathic physician and clinical researcher specializing in integrative cancer care. After graduating from Southwest College of Naturopathic Medicine and Health Sciences, she completed an NIH/ NRSA clinical research fellowship at the University of Washington in Seattle and then continued her clinical training as a Resident in Naturopathic Oncology at the Cancer Treatment Centers of America in Philadelphia.
Dr. Havens’ practice focuses on precision complimentary and integrative protocols for patients with cancer, informed by genomic analysis and quantitative cellular nutrient status. Prior to becoming a naturopathic physician, Dr. Havens received her doctoral training at the University of Virginia in the Department of Molecular and Cancer Biology after which she continued as a researcher specializing in DNA-based molecular diagnostics. Her background in cancer biology and genomics, coupled with her training as a naturopathic physician, makes her uniquely qualified to create integrative treatment protocols driven by patient-specific genetic analysis.
Dr. Havens’ current research investigates the effects of somatic hyper and hypomethylation on tumor biology during both conventional and integrative treatment, as well as the use of natural products to modulate methylation both during treatment and during survivorship. Additionally, she is investigating the role of natural products in conjunction with Viscum album extract (VAE) therapy and modulation of progression of disease in patients using conventional chemotherapeutics and patients who have failed all lines of conventional therapy. You can see a full list of Dr. Havens' qualifications below.
Click here to request an appointment with Dr. Jennifer Havens, ND, or call 480.428.3232.
Doctorate of Naturopathic Medicine, Southwest College of Naturopathic Medicine, 2015
Bachelors of Science, Biology and Chemistry, University of Central Arkansas, 1996
NIH T90 Ruth L. Kirschstein National Research Service Award (NRSA) Post Doctoral Fellowship, University of Washington
Pathogenic Yersinia DNA in Intestinal Specimens of Pediatric Patients with Crohn's Disease. Fetal Pediatr Pathol. 2013 Apr 23 Leu SB, Shulman SC, Steelman CK, Lamps LW, Bulut OP, Abramowsky CR, Gold BD, Szlam S, Stockwell C, Havens J, Kolta S, Shehata BM.
Evaluation of immunohistochemistry in identifying Bartonella henselae in catscratch disease. Am J Clin Pathol. 2009 Feb ;131 (2):250-6 Gabriel C Caponetti, Liron Pantanowitz, Sharon Marconi, Laura W Lamps, Jennifer M Havens, Christopher N Otis.
Molecular biogrouping of pathogenic Yersinia enterocolitica: development of a diagnostic PCR assay with histologic correlation. American Journal of Clinical Pathology 2006 May;125(5):658-64. Lamps LW, Havens JM, Gilbrech LJ, Dube PH, Scott MA.
AANP, American Association of Naturopathic Physicians OCT 2010-Current
AzNMA, Arizona Naturopathic Medical Association OCT 2010-Current
OncANP, Oncology Association of Naturopathic Physicians OCT 2012-Current
SIO, Society of Integrative Oncology AUG 2014-Current
American Society of Clinical Oncology JAN 2015-Current
International Congress on Integrative Medicine and Health April 2016-Current